Cutia Therapeutics (2487.HK)

HKD 6.95

(0.14%)

Operating Income Summary of Cutia Therapeutics

  • Cutia Therapeutics's latest annual operating income in 2023 was -539.65 Million CNY , down -0.26% from previous year.
  • Cutia Therapeutics's latest quarterly operating income in 2024 Q2 was -109.87 Million CNY , down 0.0% from previous quarter.
  • Cutia Therapeutics reported an annual operating income of -538.28 Million CNY in 2022, down -71.44% from previous year.
  • Cutia Therapeutics reported an annual operating income of -313.98 Million CNY in 2021, down 0.0% from previous year.
  • Cutia Therapeutics reported a quarterly operating income of -109.87 Million CNY for 2024 Q1, up 32.34% from previous quarter.
  • Cutia Therapeutics reported a quarterly operating income of -162.4 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Cutia Therapeutics (2023 - 2021)

Historical Annual Operating Income of Cutia Therapeutics (2023 - 2021)

Year Operating Income Operating Income Growth
2023 -539.65 Million CNY -0.26%
2022 -538.28 Million CNY -71.44%
2021 -313.98 Million CNY 0.0%

Peer Operating Income Comparison of Cutia Therapeutics

Name Operating Income Operating Income Difference
Uni-Bio Science Group Limited 67.76 Million HKD 896.326%
CK Life Sciences Int'l., (Holdings) Inc. 897.95 Million HKD 160.098%